Skip to content

IV SafeLock Device Functionality in Emergency Department

Functionality of the IV SafeLock Device in Emergency Department Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05695183
Enrollment
20
Registered
2023-01-23
Start date
2023-07-22
Completion date
2023-10-06
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravenous Access

Brief summary

The purpose of this research study is to evaluate the functionality of the IV SafeLock in the clinical emergency department setting.

Interventions

DEVICEIV SafeLock

Designed to prevent patient access to intravenous lines in the hospital setting. The device locks with an institution specific key and protects the hub as well as all tubing access points.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Emergency Department nurses who are consenting and willing to perform tasks. * Their patient population will include stable patients 18 or over, who present through triage, are medically stable, are able to verbally consent and require intravenous access.

Exclusion criteria

* Emergency Department nurses who are unwilling to consent to use IV SafeLock on their patient population. * The patient population will exclude pregnant patients, children, prisoners, patients with dementia, or any member of protected class as specified by IRB. * The patients must be medically stable and not include patients presenting with acute stroke, acute myocardial infarction, severe sepsis or shock.

Design outcomes

Primary

MeasureTime frameDescription
Functionality of the IV SafeLockBaselineMeasured on a likert scale for nurse evaluation of IV SafeLock

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026